The 2-minute Walk Test in Hemodialysis Patients

November 3, 2024 updated by: Merve Firat, Kirsehir Ahi Evran Universitesi

Validity and Reliability of the 2-minute Walk Test in Hemodialysis Patients

Walking tests are widely used to assess functional capacity in different populations because of their ease of administration, interpretability and representativeness of activities of daily living.The aim of our study was to investigate the validity and reliability of the 2-minute walk test in hemodialysis patients.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Hemodialysis patients who are clinically stable, between 18 and 80 years of age, who are being followed up at the Hemodialysis Unit of Kırşehir Education and Research Hospital, who do not have any exclusion criteria, who can adapt to the evaluations to be made, who are willing to volunteer and who sign the informed consent form will be included in the study.

Description

Inclusion Criteria:

  • Patients with end stage renal disease receiving hemodialysis
  • Being clinically stable
  • Being Aged between 18-80
  • Volunteering to participate in this study

Exclusion Criteria:

  • Having a musculoskeletal problem that may affect functional capacity measurement
  • Having had a cardiac event in the past 3 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise capacity
Time Frame: 5 minutes
Will be assessed using the 2 minute walk test.
5 minutes
Exercise capacity
Time Frame: 10 minutes
Will be assessed using the 6 minute walk test.
10 minutes
Muscle functions
Time Frame: 1 minutes
Will be evaluated with 1 minute sit-stand test.
1 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: 5 minutes
Will be evaluated using International Phsyical Activity Questionnaire-Short form
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kirsehir Ahi Evran Universitesi

Investigators

  • Principal Investigator: Merve Firat, Kirsehir Ahi Evran University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2024

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

October 18, 2024

First Submitted That Met QC Criteria

October 18, 2024

First Posted (Actual)

October 21, 2024

Study Record Updates

Last Update Posted (Estimated)

November 5, 2024

Last Update Submitted That Met QC Criteria

November 3, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-13/113

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End Stage Renal Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe